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Summary
Risk of cutaneous malignant melanoma (CMM) is in-
creased in sun-exposed whites, particularly those with a
pale complexion. This study was designed to investigate
the relationship of the melanocortin-1 receptor (MC1R)
genotype to CMM risk, controlled for pigmentation phe-
notype. We report the occurrence of five commonMC1R
variants in an Australian population-based sample of
460 individuals with familial and sporadic CMM and
399 control individuals—and their relationship to such
other risk factors as skin, hair, and eye color; freckling;
and nevus count. There was a strong relationship be-
tween MC1R variants and hair color and skin type.
Moreover, MC1R variants were found in 72% of the
individuals with CMM, whereas only 56% of the con-
trol individuals carried at least one variant ( ),P ! .001
a finding independent of strength of family history of
melanoma. Three active alleles (Arg151Cys,Arg160Trp,
and Asp294His), previously associated with red hair,
doubled CMM risk for each additional allele carried
(odds ratio 2.0; 95% confidence interval 1.6–2.6). No
such independent association could be demonstrated
with the Val60Leu and Asp84Glu variants. Among pale-
skinned individuals alone, this association between
CMM and MC1R variants was absent, but it persisted
among those reporting a medium or olive/dark com-
plexion. We conclude that the effect that MC1R variant
alleles have on CMM is partly mediated via determi-
nation of pigmentation phenotype and that these alleles
may also negate the protection normally afforded by
darker skin coloring in some members of this white
population.
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Introduction
Melanoma is a disease that presents in a number of
forms (Balch et al. 1992). The most common form in
whites is cutaneous malignantmelanoma (CMM),which
usually begins with a radial proliferation of melanocytes
that is followed by a vertical growth phase in which
metastasis may occur. Definition of the genes involved
in the etiology of CMM (MIM 155600 and MIM
155601) has been difficult, except in cases of very strong
familial risk (Hayward 1996). However, multiple phe-
notypic risk factors, including the number of melano-
cytic nevi (moles), freckling tendency, presence of dys-
plastic nevi, propensity to sunburn, and number of
severe sunburn episodes during youth, have been iden-
tified in the etiology and pathogenesis of this disease
(Tilgen 1993; Bliss et al. 1995). Evidence suggests that
an individual’s susceptibility to CMM may be deter-
mined through the interaction between the pigmentary
system and solar UV light (Bliss et al. 1995; Breitbart
et al. 1997), with lighter skin tones and red hair color
significantly increasing the risk of melanoma (Garbe et
al. 1994; Grange et al. 1995; Grulich et al. 1996).
That whites have a far higher incidence of CMM than
do other populations suggests that deficientmelanization
removes the protective sun-shielding effects of pigmen-
tation and, hence, increases the genotoxic effects of sun-
light. However, the absolute amount of melanin depos-
ited in the skin must also be viewed in light of the fact
that some melanins and melanogenic precursors can be
mutagenic or cytotoxic (Urabe et al. 1994). It has been
noted that whites have more of the red/yellow pheo-
melanin, which can contribute to the generation of mu-
tagenic photoproducts after exposure to UV light (Hill
et al. 1997), and that this may lead to a higher incidence
of CMM. Hence, characterization of human pigmen-
tation genes involved in the pathway of melanin for-
mation is needed to give a genetic explanation for the
deposition of different amounts and types of melanin in
the skin (Sturm et al. 1998). In the present study, we
analyze known polymorphisms in the human melano-
cortin-1 receptor gene (MC1R [MIM 155555], located
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on 16q24) involved in pigmentation, to assess their re-
lationship to CMM risk.
The MC1R gene is remarkably polymorphic in whites
(Valverde et al. 1995; Box et al. 1997; Smith et al. 1998),
and there are several reasons to suggest that particular
human MC1R alleles may be associated with increased
CMM susceptibility. MC1R encodes the melanocyte-
stimulating hormone receptor (MSHR), a member of the
G-protein–coupled receptor superfamily, whose mem-
bers can act as oncogenes in other systems (Coughlin
1994). However, there is no evidence that this is the
mechanism of action of MC1R in CMM. During ex-
posure of the skin to UV light, there is an increase in
melanin production, through the tanning response, that
may occur via an increase in tyrosinase gene transcrip-
tion and enzyme activity (Gilchrest et al. 1996; Sturm
1998). It has also been shown that exposure to sunlight
increases the levels of a-melanocyte-stimulating hor-
mone and proopiomelanocortin peptides in the skin
(Slominski et al. 1993), suggesting that one of the actions
of solar UV may be mediated through the MSHR path-
way, to stimulate cAMP (Pawelek et al. 1992) as well
as other signal-transduction pathways (Romero-Graillet
et al. 1996). MSHR is also known to be involved in
directing the production of the two distinct melanin
types, red/yellow pheomelanin and black/brown eume-
lanin, with particular human MC1R alleles associated
with red hair and fair skin (Valverde et al. 1995; Box
et al. 1997).
In addition to defining a consensus MC1R allele se-
quence by comparison of Chinese and white individuals
encoding the 317-amino-acid MSHR protein, we found
13 variant MC1R alleles in the analysis of twins, sibs,
and parents collected in southeast Queensland, Australia
(Box et al. 1997; Sturm et al. 1998), for a study of the
genetics of mole formation (Zhu et al. 1999). Three of
these MC1R alleles—Arg151Cys, Arg160Trp, and
Asp294His—were statistically associated with red hair;
one allele, Val60Leu, was associated with blonde/light
brown hair, and any variation from the consensus allele
was associated with lighter skin tones (Box et al. 1997;
Smith et al. 1998). Therefore, not only is the level of
melanin pigment in the human skin dependent on the
MC1R genotype, but it is also dependent on the pheo-
melanin/eumelanin pigment type. MC1R genotype may
well be involved in determination of the tanning re-
sponse of skin to UV light, which can then either ame-
liorate or exacerbate the genotoxic effects of sunlight,
depending on the properties of melanin precursors and
pigment induced.
In an earlier study, the Asp84Glu MC1R allele that
was also found in our Queensland population was re-
ported to be present, at higher frequency, in a collection
of British patients with sporadic melanoma (Valverde et
al. 1996). In addition, MC1R variants may modify mel-
anoma risk in Dutch families with familial melanoma
(Frants et al. 1996). Because the overall importance of
MC1R gene variation in the etiology of CMM in the
general population is unknown, we sought to examine
the association between several major MC1R variants
and melanoma risk in a population-based sample of fam-
ilies ascertained through probands with CMM and in
unselected controls from the same population.
Subjects and Methods
Subjects
Family ascertainment and data collection of CMM
case samples have been described in detail elsewhere
(Aitken et al. 1996, 1999). In brief, patients with CMM
were ascertained from a population-based cancer reg-
ister, and family members were followed up by use of a
sequential sampling scheme. Two control groups were
used for comparison of MC1R allele frequencies. The
first control group included a sample of 218 parents of
twins who were subjects in a study of the genetics of
mole formation (Box et al. 1997; McGregor et al. 1999).
The second control group comprised 181 unrelated in-
dividuals, sampled at random from 3,300 participants
in a twin study of the inheritance of alcohol use, who
had been drawn from the Australian Twin Registry
(Heath et al. 1997). This project received ethics approval
from our institutional ethics committee.
Measures
CMM case samples.—The total sample of 1,897 fam-
ilies available for this study was divided into three strata
of familial melanoma risk—low, intermediate, and
high—by use of a permutation procedure described else-
where (Aitken et al. 1994, 1999). We attempted to ob-
tain, in each of the 91 high-risk families, blood samples
from two individuals with CMM, sampled at random
from all patients in the family, and from one individual
with CMM in each of 200 intermediate-risk families and
200 low-risk families, selected at random. If no cases
were available in a selected intermediate-risk or low-risk
family, the next random number was chosen, until 200
families in each group had been recruited. Ultimately,
data on patients from 482 families were obtained.
Standard risk factors for melanoma, including pro-
pensity to burn in the sun, pigmentation (skin color, hair
color at 21 years, eye color, total freckling in summer,
and density of melanocytic nevi) were sought by means
of a mailed questionnaire. Of a total of 7,619 living
relatives, 5,158 (68%) responded after intensive tele-
phone follow-up. Index patients and other family mem-
bers provided proxy reports (the quality of which we
have previously reported [Aitken et al. 1993]) for an
additional 4,588 relatives, providing a total of 9,746
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relatives with risk-factor information. Only medically
verified cases among relatives were included in the anal-
ysis. Hair color was recorded as being either black, dark
brown, light brown, fair, or red/auburn, and skin color
was recorded as being either fair, medium, or olive/dark.
A three-point scale was also used for eye color, which
included the categories “blue/gray,” “green/hazel,” and
“brown.” Total freckling in summer was self-reported
as being either nil, 1–100, or 1101, and density of me-
lanocytic nevi was estimated by use of a scale including
the categories “nil,” “few,” “moderate,” or “many.”
Control sample 1: parents of twin mole-study mem-
bers.—Skin, hair, and eye color and mole counts have
been recorded for most of the parents of twinmole-study
members genotyped in this analysis, by use of measures
identical to those used to record these characteristics in
the individuals with CMM. However, a four-point scale
was used to record freckle density, including no freckling
and the presence of a few, some, and many freckles.With
regard to the parents of twin mole-study members, a
research nurse categorized each individual rather than
relying on self-report.
Control sample 2: twin alcohol-study members.—
Only hair and eye colors have been recorded for those
individuals selected from the twin study of the inheri-
tance of alcohol use, by use of measures identical to those
used for both the individuals with CMM and the parents
of twin mole-study members. The members of this study
were phenotypically characterized by self-report.
Genotyping
DNA extraction, PCR amplification, agarose-gel elec-
trophoresis, and filter blotting.—After extraction of
DNA by standard methods (Miller et al. 1988), the
nested primer strategy, described elsewhere (Box et al.
1997), was used to obtain sufficient DNA for dot blot-
ting and for identification of MC1R alleles. Sequential
Taq DNA polymerase amplifications were done in 96-
well plates with 25–50-ml total volumes containing 10%
dimethyl sulfoxide, starting with 25 ng genomic DNA
and with the second reaction being initiated by use of
5 ml of the first-round reaction as template. Products
from these amplifications were checked by running 2 ml
on 1% agarose gels; equivalent amounts were then blot-
ted onto dry nylon membrane (Magna; Micron Sepa-
rations), and dots were allowed to air-dry. The mem-
brane was placed on filter paper soaked in 0.5MNaOH/
1.5 M NaCl denaturation solution, 0.5 M Tris-Cl pH
7.5/1.5 M NaCl neutralization solution, and 2 # SCC
rinse solution, each for 5 min. DNA was cross-linked to
the filters, either by baking for 2 h at 80C or by UV
cross-linking.
Allele-specific oligonucleotide hybridization and op-
timization.—Probes were designed as 15-base allele-spe-
cific oligonucleotides, with the mismatch centrally po-
sitioned to provide maximal binding stability to the
complementary sequence and instability of a mismatch.
A total of 100 ng each oligonucleotide was radiolabeled
with g[32P]-ATP, by use of polynucleotide kinase (NEB),
and was fractionated from unincorporated nucleotide by
use of chromatography on Sephadex G-25 (Pharmacia
NAP 5 columns). Filters were prehybridized at 42C for
2 h, in the presence of tetramethylammonium chloride
(TMAC) (Wood et al. 1985) in 10 ml of 3 M TMAC,
0.1% SDS, 1 mM EDTA, 25 mM Na3PO4 pH 6.8, 5#
Denhardt’s solution, and 0.1 mg herring-sperm DNA
per ml (Shuber et al. 1993). A total of 50 ml radiolabeled
probe, equating to cpm hybridization so-5 2.75# 10
lution per ml, was added directly to the prehybrization
solution and was left to hybridize overnight at 42C.
The probe was denatured by being heated to 70C for
5 min and was then quenched on ice before being added
to the mix. Filters were rinsed in 3 M TMAC, 0.1%
SDS, 1 mM EDTA, and Na3PO4 pH 6.8 wash solution
at room temperature for 5 min; this was followed by a
single 20-min wash at 50C before autoradiographic ex-
posure.
This method is capable of detection of single-base
changes through different-temperature washes of oli-
gonucleotides, and, with the addition of the TMAC salt
in the hybridization cocktail and posthybridization
washes, it can control the conditions of washing as a
function of probe length and can select for exactly
matching oligonucleotides (Wood et al. 1985; Shuber et
al. 1993). Six MC1R variants (Val60Leu, Asp84Glu,
Arg151Cys, Arg160Trp, Asp294His, and 537insC)were
chosen for analysis, and oligonucleotides corresponding
to the consensus or variant nucleotide substitutions and
insertion were synthesized (table 1). These radiolabeled
oligonucleotides were hybridized to MC1R PCR frag-
ments that were blotted onto test filters corresponding
to homozygote-consensus, heterozygote (1:1 mixture of
consensus and variant), or homozygote-variant alleles.
The signals generated after a washing at 50C were vi-
sualized by autoradiography (fig. 1).Mismatched probes
were effectively washed from the respective homozygote-
dotted sample on each filter, with the positive and neg-
ative hybridization signal easily indicating the presence
of MC1R homozygous-consensus or homozygous-vari-
ant alleles. In each case, the dotted sample representing
heterozygosity of the MC1R PCR fragment showed a
lower level of hybridization than did the homozygous
state, with each of the consensus and variant oligonu-
cleotides. These control experiments verified the differ-
ential hybridization-screening procedure, which was
then used to determine the MC1R genotype at each of
these positions in our sample collections.
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Table 1
MC1R Allele-Specific Oligonucleotides and Variant Frequency in
Control-Sample Subjects
VARIANT
ALLELE SAMPLE
VARIANT
AND
AMINO ACID
OLIGONUCLEOTIDEa
(5′r3′) 1b 2c
ALLELE
FREQUENCYd
(%)
V60L:
Val gctggtggtggccac
Leu gctggtgTtggccac 57 39 12.0
D84E:
Asp tgtcggacctgctgg
Glu tgtcggaActgctgg 7 5 1.5
R151C:
Arg cgcactgcgctacca
Cys cgcactgTgctacca 48 23 8.9
R160W:
Arg cctgccgcgggcgcg
Trp cctgccgTgggcgcg 30 31 7.6
D294H:
Asp catcatcgaccccct
His catcatcCaccccct 10 15 3.1
537insC:
Wild type gctcttcatcgccta
InsC gctcttcCatcgcct Nil Not done .0
a Nucleotide substitutions and insertion are shown in uppercase and
are underlined.
b Collected as parents of twins representing 436 haplotypes.
c Collected for a study of alcoholism representing 362 haplotypes.
d In the 798 haplotypes examined.
Figure 1 Use of allele-specific oligonucleotides for MC1R ge-
notyping. A total of 100 ng each of PCR-amplified MC1R consensus
and variant product were bound both independently (homozygote)
and as an equimolar mixture (heterozygote) to nylon membranes and
were hybridized with consensus or variant 15-base oligonucleotides,
as indicated. Hybridization and washing of the [32P]-labeled oligo-
nucleotides, in the presence of TMAC, differentiates each of the six
MC1R variants examined in this study.
Statistical Analysis
Most analyses were done by use of SAS, version 6.11
(SAS Institute 1998), including log-linear and multino-
mial regression modeling done by means of SAS PROC
CATMOD. Exact tests for combination of 2# 2 tables
were done by use of the program IC2X2 (Thomas and
Gart 1992). Pairwise linkage disequilibrium was as-
sessed by use of the program ASSOCIATE 2.33 (Ott
1996) and was quantified as the standardized pairwise
disequilibrium coefficient (D′) (Weir 1996).
Results
Phenotypes of Control Individuals and Individuals with
CMM
One important step in this analysis was to ensure that
the control individuals chosen were, in fact, represen-
tative of the Queensland population and were compa-
rable to individuals with CMM. Sex ratios of those with
CMM and of control individuals were not significantly
different (60.0% female; ), but control individ-P = .16
uals were, on average, 12 years younger (age 47 years)
than the individuals with CMM (age 60 years). Table 2
summarizes the sample numbers, according to pheno-
typic data collected for each part of the study. Prelimi-
nary analyses of the two control groups showed that
they did not differ significantly in distribution of MC1R
variants; ancestry; or eye, hair, or skin color; therefore,
they have been combined in subsequent analyses. The
distributions of eye and hair color were similar to those
seen in other Australian (Mitchell et al. 1998) or white
(Bliss et al. 1995) samples. With regard to ancestry, 86%
of the overall sample had origins in the British Isles (32%
from Ireland, Scotland, and Wales); 9%, in northern
Europe; and 2%, in southern Europe.
Frequency of MC1R Variants in Control Populations
and Populations with CMM
The allele frequencies of six MC1R variants (Val
60Leu, Asp84Glu, Arg151Cys, Arg160Trp, Asp294
His, and 537insC) in the control samples are shown in
table 1. Individuals who were homozygous for the con-
sensus MC1R sequence at these positions were 44.6%
of the control population, and no control individual car-
ried more than two variants (in contrast to the individ-
uals with melanoma cases [see data that follow]). The
537insC insertion was not detected in these control sam-
ples, indicating that it is a rare variant within the south-
east Queensland population. Despite the individual rar-
ity of the Asp84Glu and Asp294His variants, five
subjects carried both alleles, giving a maximum-likeli-
hood estimate of 0.6% for the Asp84Glu/Asp294His
haplotype frequency (expected frequency, under the as-
sumption of no intragametic association 0.05%; P !
)..001
When we examined the entire sample (table 2), we
found a total of 128 (14.9%) individuals carrying two
variants and 8 individuals (all of whom had CMM) car-
rying three variants (5 individuals had Asp84Glu,
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Table 2
Phenotypic Characteristics, in Patients with CMM and in Control Subjects
NO. OF SUBJECTS IN EACH
MELANOMA-RISK GROUPa
TOTAL NO. (%)
OF SUBJECTSb
PHENOTYPE AND MEASURE High Intermediate Low With CMMc Controlsd
Hair color:
Red/auburn 7 20 23 50 (11.6) 24 (6.2)
Fair 14 51 56 121 (28.0) 58 (15.0)
Light brown 25 64 60 149 (34.5) 138 (35.8)
Dark brown 12 45 42 99 (22.9) 144 (37.3)
Black 2 6 5 13 (3.0) 22 (5.7)
Total 60 186 186 432 386
Skin color:
Fair 42 141 133 316 (73.5) 122 (58.9)
Medium 14 39 48 101 (23.5) 70 (33.8)
Olive/dark 4 5 4 13 (3.0) 15 (7.2)
Total 60 185 185 430 207
Eye color:
Blue/gray 25 77 92 194 (45.4) 148 (38.0)
Green/hazel 22 81 59 162 (37.9) 145 (37.5)
Brown 12 28 31 71 (16.6) 95 (24.4)
Total 59 186 182 427 388
Freckles:
Nil 18 49 50 117 (29.0) 66 (32.2)
Any 39 123 125 287 (71.0) 139 (67.8)
Total 57 172 175 404 205
Moles:
Nil 2 17 19 38 (9.8) 9 (4.3)
Few 24 60 86 170 (43.8) 138 (66.8)
Moderate 25 61 57 143 (36.9) 48 (23.1)
Many 7 19 11 37 (9.5) 12 (5.8)
Total 58 157 173 388 207
a Melanoma-risk–group division is according to Aitken et al. (1994).
b Complete phenotypic data are available for only a subset of patients with melanoma and
of control subjects. Data are most complete for hair and eye color. Skin and mole count are
not available for one set of control subjects.
c Total number phenotyped = 432; total number genotyped = 460.
d Total number phenotyped = 389; total number genotyped = 399.
Arg160Trp, and Asp294His; 2 had Asp84Glu, Arg151
Cys, and Asp294His; and 1 had Val60Leu, Asp84Glu,
and Asp294His). In one individual, the presence of pa-
rental data (not shown) allowed phase to be inferred
and confirmed that the person was carrying an Asp
84Glu, Asp294His chromosome. Calculation of D′ val-
ues found statistically significant evidence of allelic as-
sociation for four pairs of loci (table 3).
Association between MC1R Genotype and Skin and
Hair Pigmentation
The relationship between hair color and MC1R var-
iants is represented in figure 2. The association between
total number of variants carried and red hair is striking
( ): 160% of redheads carried two or three var-P ! .001
iants, and none carried the consensus genotype. Al-
though carriage of the Arg151Cys, Arg160Trp, and
Asp294His variants increased the probability of being
redheaded (odds ratio [OR] 23; 95% confidence interval
[CI] 13–42; reference, consensus homozygote), the
Val60Leu variant was more common among those with
other hair colors ( ).P = .015
Self-reported data on constitutive skin color was avail-
able for 628 individuals (one control group was not
asked about this)—433 with fair or pale skin, 167 with
medium skin color, and 28 with brown or olive skin.
The frequency of Arg151Cys ( ), Arg160TrpP ! .001
( ), and Asp294His variants, which reflected theP = .004
correlation between hair color and skin color, was in-
creased ( ) within the fair-skinned group (fig. 3).P = .02
However, the association persisted after stratification
was done on the basis of ethnicity and hair color, sug-
gesting that this was not a result of either systematic
error in reporting or ethnicity. The frequency of the
Val60Leu allele increased slightly, although not signifi-
cantly so, with increasing pigmentation ( ). Sim-P = .59
ilar trends were observed for freckling, which persisted
after adjustment for hair color—for example, for the
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Table 3
Standardized Pairwise Disequilibrium Coefficients (D′) for Each
MC1R Variant
D′
MC1R
VARIANT
V60L
( a)P = .82
D84E
( a)P = .46
R151C
( a)P = .31
R160W
( a)P = .01
D294H
( a)P = .25
V60L )
D84E .05 )
R151C .15b .05 )
R160W .12b .01 .13b )
D294H .01 .45b .04 .06 )
a Hardy-Weinberg equilibrium.
b Significantly different from 0.
Figure 2 Association of MC1R variants with hair color. The
percentage of individuals carrying a variant MC1R genotype at the
five positions tested is shown, plotted against hair color. At the left-
hand side of the graph are the frequencies of the MC1R consensus
genotype, represented by “0,” and the total for any variant genotype,
represented as “1,” “2,” or “3” variants, in the 818 samples geno-
typed, for which hair-color data, which sums to 100% for each hair
color, are available (table 2). The absolute percentage of each variant
position considered to be independently carried on one or both alleles,
represented as “1” or “2,” is also plotted against hair color, which is
on the right-hand side of the graph.
Arg151Cys variant versus absence or presence of freck-
ling, the Mantel-Haenszel pooled OR was 2.1 (95% CI
1.3–3.3). By contrast, an association between eye color
and MC1R genotype was not detectable in this sample.
Similarly, althoughMC1R genotype was correlated with
hair color and although hair color was significantly as-
sociated with mole count (with fair hair correlating with
increased mole count and red and dark hair correlating
with decreased mole count), MC1R genotype was un-
correlated with mole count in stratified analyses (P =
)..30
Association of MC1R Genotype with CMM
Initially, we examined the known phenotypic risk fac-
tors for CMM. Individuals with CMMwere significantly
more likely to have fair (OR 2.0 [95% CI 1.5–2.8] ref-
erence category, black or dark brown) or red (OR 1.9
[95% CI 1.2–3.1]) hair; their eyes tended to be blue/
gray (OR 1.8 [95% CI 1.2–2.7] reference category,
brown) or hazel/green (OR 1.6 [95% CI 1.1–2.3]); and
their constitutive skin color was lighter than that seen
in controls, even after stratification was done on the
basis of ethnic background (Mantel-Haenszel OR 2.0
[95% CI 1.4–2.9]; reference category, moderate or olive/
dark). Finally, individuals with CMM had greater num-
bers of moles (46% reported a moderate number of or
many moles) than did controls (29% OR 2.0 [95% CI
1.3–3.2] adjusted for hair color).
All five of the MC1R variants tested—most notably,
Arg151Cys, Arg160Trp, and Asp294His—were more
common in individuals with CMM than in controls (ta-
ble 4; ); however, after adjustment for both theP ! .001
presence of other variants and, specifically, the linkage
disequilibrium between Asp84Glu and Asp294His, only
the three aforementioned variants have ORs that are
significantly 11. The odds of CMM occurring increased
2.2-fold (95% CI 1.6–3.0) in individuals carrying one
of these three “active” variants, and it increased 4.1-fold
(95% CI 2.1–7.9) if at least two variants were carried.
In analyses done with adjustment for ethnicity, hair
color, and skin color (table 5), we found that this risk
gradient was abolished in the fair-skinned group, espe-
cially after adjustment for hair color, which was a sig-
nificant risk factor. Carrying a single MC1R variant per-
sisted in being associated with increased melanoma risk
( ) in the subgroups with a medium or olive/darkP = .004
complexion (OR 2.2 [95% CI 1.2–4.1] and 10.8 [95%
CI 1.2–95.6], respectively), but it had its greatest effects
in individuals of non-British descent (test for interaction,
).P = .02
Within the sample of individuals with CMM, there
was no relationship between strength of family history
(risk group) and MC1R genotype ( ). By contrast,P = .27
there was a significant correlation between mole count
and family risk index in this sample (Aitken et al. 1996).
Discussion
Two of the most prominent phenotypic risk indicators
for CMM are an increased number of moles (Swerdlow
and Green 1987) and the red-hair–pigmentation phe-
notype (Bliss et al. 1995; Grange et al. 1995). An in-
creased number of moles exhibits a complex relationship
with other pigmentary characteristics, although it is no-
table that mole counts have been reported to diminish
in those individuals with red hair. It is clear that red hair
is also associated with other pigmentary characteris-
tics—including skin color, freckling, propensity to burn,
and failure to tan—that are, in turn, indicators of CMM
risk. The purpose of this investigation was to examine
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Figure 3 Association of MC1R variants with skin color. The
percentage of individuals carrying a variant MC1R genotype at the
five positions tested is shown, plotted against skin color. At the left-
hand side of the graph are the frequencies of the MC1R consensus
genotype, represented by “0,” and the total for any variant genotype,
represented as “1,” “2,” or “3” variants, in the 637 samples geno-
typed, for which skin-color data, which sums to 100% for each skin
color, are available (table 2). The absolute percentage of each variant
position considered to be independently carried on one or both alleles,
represented as “1” or “2,” is also plotted against skin color, which is
on the right-hand side of the graph.
Table 4
Risk of CMM for Each MC1R Variant
Variant Allele OR (95% CI) of CMM
V60L 1.3 (.9–1.7)
D84E .8 (.3–1.9)
R151C 2.1 (1.6–3.0)
R160W 1.9 (1.3–2.7)
D294H 2.3 (1.3–4.1)
NOTE.—Logistic-regression analysis includes
all variants simultaneously; the consensus se-
quence is the reference category.
the underlying genetic relationship between these traits
and the incidence of CMM, by assaying the frequencies
of five of the more common MC1R variants found in
whites in a collection of Queensland patients who had
CMM.
We have used a large sample of patients with CMM
and control individuals from the same population to
show that an association between MC1R variants and
melanoma risk exists and is mediated, in part, through
known skin- and hair-pigment phenotypes, but in a com-
plex fashion. A possible caveat of this interpretation is
the degree to which the control individuals are repre-
sentative of the Queensland population from which the
patients with CMM were ascertained. They were, how-
ever, similar with regard to the range of pigmentation
phenotypes that could be measured and compared with
those found in other Australian studies (Mitchell et al.
1998). We have also examined the details of the rela-
tionship between MC1R variants, skin coloring, and
hair coloring in the combined representative population
sample.
Although the relationship between pigmentary phe-
notype and risk of melanoma has been well studied by
epidemiologists, the role of the genes involved in pigment
formation has yet to be fully assessed. Variants in the
MC1R gene have previously been shown to be associ-
ated with red hair, pale skin, and freckling (Valverde et
al. 1995; Box et al. 1997; Smith et al. 1998), and two
groups have examined the relationship between partic-
ular MC1R variants and CMM. One group, led by Jon-
athan Rees (Valverde et al. 1996; Healy et al. 1999),
genotyped 43 patients with CMM and 44 control in-
dividuals and found that carrying a variant allele in-
creased the risk of melanoma 3.9-fold. It was reported
that the Asp84Glu variant was found only among in-
dividuals with CMM, and, in contrast to the findings of
that report, our results did not show a particular rela-
tionship between Asp84Glu and CMM. However, both
the results of a later reanalysis (Healy et al. 1999) of the
low frequency of this variant and the small sample size
of the original study show that this variant is unlikely
to be a major risk factor for CMM.
Another group, led by Richard Strange (Ichii-Jones et
al. 1998; Strange et al. 1999), found the frequencies of
the Asp84Glu and Asp294His variants to be 1.7% and
3.4%, respectively, in a series of 190 English patients
with basal-cell carcinoma—very similar to the results
obtained in our control group, which is largely of British
descent. Asp294His was associated with red hair color
(crude OR 5; exact ; see Strange et al. [1999])P = .012
but not with skin type. Most critically, although these
variants were not more common overall among 306 in-
dividuals with melanoma compared with 190 control
individuals, they showed increased frequency among
individuals with greater tanning ability (in Fitzpatrick
skin types 3 and 4 [crude OR 3.9 {95% CI 1.7–9.3}] vs.
wild-type homozygotes). Our study could detect signif-
icant association between specific variants, such as
Asp294His, and CMM that the study by Ichii-Jones et
al., possibly as a result of their smaller sample size, could
not detect. The strong linkage disequilibrium between
Asp84Glu and Asp294His in the present study’s pop-
ulation means that it is harder to demonstrate a rela-
tionship between Asp84Glu and phenotype. Valverde et
al. (1996) have pointed out that the codon 84 aspartate
is highly conserved in the melanocortin receptor and in
other G-protein–coupled receptor families and suggests
that the glutamate substitution is likely to be functionally
significant. Given its rarity relative to the other variants,
it cannot explain much of the population variation in
skin color and hair color.
We have found the Arg151Cys, Arg160Trp, and Asp
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Table 5
Association between MC1R Variants and CMM Risk, Stratified on
the Basis of Skin and Hair Color
PERCENT (NO.) WHO
HAVE MC1R VARIANT
SKIN COLOR
AND HAIR COLOR
Individuals
with CMM
Control
Individuals
Adjusted ORa
(95% CI)
Not available:
Red/auburn 100.0 (11)
Fair 66.7 (27)
Light brown 50.8 (65)
Dark brown 47.8 (69)
Black 62.5 (8)
Total (180)
Fair: 1.2 (.7–1.9)
Red/auburn 100.0 (45) 100.0 (12)
Fair 73.6 (110) 68.0 (25)
Light brown 64.6 (99) 69.4 (49)
Dark brown 71.2 (52) 61.3 (31)
Black 62.5 (8) 42.9 (7)
Total (314) (124)
Medium: 2.2 (1.2–4.1)
Red/auburn 100.0 (4) 100.0 (2)
Fair 87.5 (8) 16.7 (6)
Light brown 56.8 (44) 54.5 (22)
Dark brown 61.9 (42) 41.7 (36)
Black 100.0 (2) .0 (5)
Total (100) (71)
Olive/dark: 10.8 (1.2–95.6)
Red/auburn .0 (0) .0 (0)
Fair 100.0 (3) .0 (0)
Light brown 100.0 (3) 25.0 (4)
Dark brown 25.0 (4) 11.1 (9)
Black 100.0 (3) 50.0 (2)
Total (13) (15)
Grand totalb 71.7 (427) 55.9 (390)
a Stratum-specific OR is adjusted for hair color, by use of the Man-
tel-Haenszel procedure.
b Total includes only those individuals with known hair color.
294His polymorphisms to be significantly associated
with CMM, as well as with skin color and hair color.
The most parsimonious explanation for the increased
incidence of melanoma in individuals with either red or
fair hair and with fair skin centers on their inability to
increase melanin levels in the skin in response to high
exposure to UV light. If this hypothesis is correct, then
stratification done on the basis of hair color and skin
color should remove any relationship between MC1R
genotypes and CMM. By contrast, the alternative hy-
potheses are either that pheomelanin, its precursors, or
photoproducts are mutagenic (Sturm 1998) or, possibly,
that, as suggested by Valverde et al. (1996), this melan-
ocortin receptor is involved in modulation ofmelanocyte
growth and differentiation.
In the present study, we found that the first hypothesis
cannot completely explain the data. Although the risk
of melanoma in fair-skinned individuals varied accord-
ing to hair color but not according to MC1R genotype,
in individuals who reported a superior tanning ability
and darker constitutive skin color, the MC1R genotype
had a persisting effect on risk, even after adjustment for
hair color, ethnic background, and mole count. Because
the frequencies of the different MC1R variants do vary
according to skin color, even when there is control for
other confounders, we believe that this argues against
the possibility that this effect is mediated solely by re-
porting bias. This explanation is made less likely by ev-
idence relating subjective reports of skin color to objec-
tive measurements of skin reflectance and to independent
clinical ratings (Green and Martin 1990; Aitken et al.
1993). Otherwise, one might suggest that light-skinned
individuals who have more exposure to the sun might
tend to report a darker skin color and might have more
melanoma.
It is tempting to speculate that individuals who, be-
cause of their darker skin color, would normally have a
decreased risk for CMMmight, if carrying a variant that
predisposes to production of pheomelanin, negate that
protection or might, if a dose effect is present, produce
more pheomelanin than would a fair-skinned individual
carrying that sameMC1R genotype. In keeping with this
suggestion is the fact that whereas, among wild-type
homozygotes, having fair skin increases the odds of
CMM 2.9-fold compared with having darker skin, the
odds ratio is only 1.2 for MC1R variant carriers (Bres-
low-Day test for difference, ).P = .02
It is also clear, from our results, that MC1R genotype
does not exert any effect on CMM risk through the
intermediate variable of mole count, especially in the
skin-color group in which its effect is greatest. In fact,
within the pale-skinned group, red hair was associated
with a decreased mole count, as has been observed in
other studies (English and Armstrong 1994; Grulich et
al. 1996). This lack of association tends to support such
mechanisms as a direct effect of pheomelanin and is
consistent with the two-hit “divergent-pathway” model
suggested elsewhere (Whiteman et al. 1998). In this
model, lifetime UV exposure (perhaps amplified by the
presence of pheomelanin) acts to increase melanoma risk
via abnormal expression of p53, and other genes, such
as CDKN2A, act by inducing melanocyte proliferation
and, thus, vulnerability to malignant transformation. Be-
cause known mutations of CDKN2A explain relatively
little of the familial aggregation of CMM, both (a) the
lack of a correlation between familial risk index and
frequency ofMC1R variants and (b) the presence of such
a correlation between familial risk and mole count sug-
gest that other loci, acting via this “nevus pathway,” are
yet to be identified, possibly close to CDKN2A itself
(Zhu et al. 1999).
The precise nature of the association between MC1R
genotype and hair color is best examined in individuals
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carrying two variants, most of whom were compound
heterozygotes. As noted, all 71 redheads in this study
carried at least one variant, and 45 carried two of the
five variants assayed by allele-specific oligonucleotides.
Although 66% of all individuals carrying two alleles
from the set including Arg151Cys, Arg160Trp, and
Asp294His were redheads, the frequency of redheads
dropped to 8% among those individuals in whom at
least one of the two alleles was Val60Leu or Asp84Glu.
In earlier work, we have shown that other MC1R var-
iants are present in the Queensland population (Box et
al. 1997). Further genotyping, plus collection of more-
precise phenotypic data in a related cohort, will allow
for better evaluation of the effects of particular vari-
ants—for example, particular shades of red hair and
with freckling. When results of such studies are com-
bined with data on parental coloring, it will be possible
to adjust for the effects of the other putative hair- and
eye-color loci (MIM 113750, MIM 227220, MIM
227240, MIM 266300, and MIM 601800).
Categorization of skin- and hair-color phenotypes is
based on broad divisions that, by their generalized na-
ture, cannot be applied as an accurate predictor of the
outcome of any individual’s lifetime sun exposure and
resultant skin-cancer rate. It is thus necessary to seek a
more direct and quantitative genotypic assessment of
risk. This is relevant even among redheads, in whom
significant heterogeneity of CMM risk may be present
and may be regulated by MC1R variation, resulting in
both visible differences in the red-hair phenotype and
more-subtle differences in the eumelanin/pheomelanin
ratio. It has been suggested that the eumelanin:pheo-
melanin ratio may differ markedly in individuals with
fairly similar red-hair pigmentation and that this ratio
may influence the minimal erythemal dose or UV sen-
sitivity within these individuals (Vincensi et al. 1998).
Current prevention strategies for melanoma and other
skin cancers rely predominantly on campaigns that are
aimed at increasing the general awareness of the dam-
aging effects of UV radiation, as well as of encouraging
those “sun-smart” behaviors that minimize levels of UV
exposure within the whole of the white population,
which is considered to be at high risk for skin cancer. It
is clear, however, that not all whites share identical risk
for skin cancers such as CMM, and better understand-
ing of the genetic basis of UV-sensitive skin types will
greatly enhance targeting of skin cancer–prevention
campaigns.
In conclusion, we have shown that carrying particular
MC1R variants increases CMM risk in individuals
whose darker complexions would normally be consid-
ered protective. In light-skinned individuals, the asso-
ciation between CMM and MC1R variants disappears
once skin- and hair-color phenotype are taken into ac-
count.
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